Payment Terms | T/T, Western Union |
Supply Ability | 2000000pcs/month |
Delivery Time | 20-30days |
Packaging Details | 1pc/pouch, 25pcs/box |
Method | Gold Colloidal |
Format | Multiple Cassette |
Specimen | Saliva |
Testing time | 5-15 minutes |
Shelf Life | 24 Months |
Application | various drug |
Brand Name | New Life |
Certification | ISO13485, CE |
Place of Origin | China |
View Detail Information
Explore similar products
TML Urine Drug Abuse Test Kit Gold Colloidal 100ng/Ml Cut Off Qualitative
Professional Tramadol Test Kit Rapid Diagnostic Card Format 24 Month Shelf Life
Rapid Diagnostic Drug Abuse Test Kit , Urine Drug Screen Kits For Morphine
CE Approved Portable Drug Test Kits 4mm Dipcard 500ng/ML Cut - Off For Ecstasy
Product Specification
Payment Terms | T/T, Western Union | Supply Ability | 2000000pcs/month |
Delivery Time | 20-30days | Packaging Details | 1pc/pouch, 25pcs/box |
Method | Gold Colloidal | Format | Multiple Cassette |
Specimen | Saliva | Testing time | 5-15 minutes |
Shelf Life | 24 Months | Application | various drug |
Brand Name | New Life | Certification | ISO13485, CE |
Place of Origin | China | ||
High Light | self testing drug kits , accurate drug test kits |
multiple cassette 6 panel Drug Testing kits Saliva, Saliva Specimen, High Accuracy, easily and quick,
Intended Use
The Oral Fluid Drug Screen Device for AMP/MET/COC/OPI/THC/BZO is a lateral flow chromatographic immunoassay for the qualitative detection of amphetamine, methamphetamine, cocaine, opiates, THC, BZO and their metabolites in oral fluids at the following cut-off concentrations:
Product | Cat No | Specimen | Sensitivity |
Drugs Testing Kits Saliva | |||
AMP | YD101S3 | Saliva | 1000 ng/mL |
YD101C4 | |||
BAR | YD201S3 | Saliva | 300 ng/mL |
YD201C4 | |||
BZO | YD301S3 | Saliva | 300 ng/mL |
YD301C4 | |||
COC | YD401S3 | Saliva | 300 ng/mL |
YD401C4 | |||
MOR(MOP) | YD501S3 | Saliva | 300 ng/mL |
YD501C4 | |||
MET | YD601SM | Saliva | 500 ng/mL |
YD601CM | |||
MTD | YD701S3 | Saliva | 300 ng/mL |
YD701C4 | |||
MDMA | YD801S3 | Saliva | 500 ng/mL |
YD801C4 | |||
THC | YD901S3 | Saliva | 50 ng/mL |
YD901C4 | |||
BUP | YD111S3 | Saliva | 100 ng/mL |
YD111C4 | |||
PCP | YD121S3 | Saliva | 25 ng/mL |
YD121C4 | |||
K2 | YD131S3 | Saliva | 50 ng/mL |
YD131C4 | |||
OPI | YD141S3 | Saliva | 2000 ng/mL |
YD141C4 |
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) and gas chromatography/tandem mass spectrometry (GC/MS/MS) are the preferred confirmatory methods. Professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
DIRECTIONS FOR USE
Allow the test, urine specimen, and/or controls to reach room temperature
(15-30ºC) prior to testing.
INTERPRETATION OF RESULTS
NEGATIVE:* Two lines appear. One colored line should be in the control region (C), and another apparent colored line adjacent should be in the test region (Drug/T). This negative result indicates that the drug concentration is below the detectable level. *NOTE: The shade of color in the test line region (Drug/T) will vary, but it should be considered negative whenever there is even a faint line.
POSITIVE: One colored line appears in the control region (C). No line appears in the test region (Drug/T). This positive result indicates that the drug concentration is above the detectable level. INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test using a new test panel. If the problem persists, discontinue using the lot immediately and contact the manufacturer.
QUALITY CONTROL
A procedural control is included in the test. A line appearing in the control region
(C) is considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique.
Control standards are not supplied with this kit. However, it is recommended that positive and negative controls be tested as good laboratory practice to confirm the test procedure and to verify proper test performance.
Company Details
Business Type:
Manufacturer,Exporter
Year Established:
2009
Total Annual:
10,000,000-15,000,000
Employee Number:
200~300
Ecer Certification:
Active Member
Established in 2009, Orient New Life Medical Co., Ltd., is specialized in high-tech biological diagnostic test development, research and production, as well as high-tech medical device development, research and production. New Life has built up two production base, which produce biological diagnosti... Established in 2009, Orient New Life Medical Co., Ltd., is specialized in high-tech biological diagnostic test development, research and production, as well as high-tech medical device development, research and production. New Life has built up two production base, which produce biological diagnosti...
Get in touch with us
Leave a Message, we will call you back quickly!